Israeli company Galmed gets positive trial results for liver drug
TEL AVIV (Reuters) - Galmed Pharmaceuticals said on Tuesday patients in a mid-stage trial for its treatment for NASH, a fatty liver disease linked to obesity, showed a statistically significant reduction in liver fat.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Eating Disorders & Weight Management | Fatty Liver Disease (FLD) | Health | Israel Health | Liver | Liver Disease | Obesity | Statistics | Urology & Nephrology